Title, Month:page

Consult Your Pharmacist

Allergic Rhinitis: Assisting Patients in Achieving Optimal Outcomes, 5:6

Common Cold, The: A Review of OTC Options, 1:6

Common Ophthalmic Conditions and Self-Care Options, 3:8

Emergency Contraception: What Pharmacists Need to Know, 9:8

Focus on Tdap, 7:6

’Tis the Season: A Focus on Influenza, 11:6

Contemporary Compounding

Amitriptyline HCl 2%, Baclofen 5%, Ketamine HCl 5%, and Ketoprofen 10% in Pluronic Lecithin Organogel, 3:42

Anhydrous Ointment for Diabetic Foot Ulcer, 10:59

Estradiol 0.25 mg/mL, Estriol 2 mg/mL, and Estrone 0.25 mg/mL Clear Topical Solution, 9:47

Ethotoin 50 mg/mL Oral Suspension, 1:47

Levofloxacin 50 mg/mL Oral Suspension, 5:46

Metronidazole 2%, Misoprostol 0.003%, Nifedipine 2%, and Phenytoin 5% Gel, 6:47

Nitrofurazone 0.02% Nasal Solution/Spray, 4:46

Omeprazole 1 mg/mL or 2 mg/mL Oral Suspension, 12:47

Phenylephrine HCl 0.5%, Naphazoline HCl 0.05%, and Pyrilamine Maleate 0.2% Nasal Spray, 7:43

Sertraline 4 mg/0.1 mL in Lipoderm, 11:47

Sildenafil Citrate 2.5 mg/mL Oral Liquid, 2:47

Testosterone 1 mg/0.1 mL Nasal Spray, 8:47

Continuing Education

Clinical Overview of DPP-4 Inhibitors for Type 2 Diabetes, A, 10:49*

Combating Opioid Abuse Through New Formulations and Policy, 3:31*

Drug-Induced Severe Cutaneous Adverse Reactions: Potential Signals of Serious Risks and New Safety Information From FAERS, 6:35*

Managing Hypertension in Older Adults: Recent Guidelines Explained, 2:37*

Managing Major Depression and Bipolar Disorder, 8:36*

Mild Cognitive Impairment Overview and Update, 11:36*

New Therapeutic Options for the Management of ADHD, 5:33*

New Vaccines and Immunization Schedule Changes, 4:37*

Pharmacologic Management of Cluster Headache, 1:35*

Prescribing Oral Contraceptives: A New Pharmacist Role, 9:36*

Preventive Treatment for Patients With Migraine and Cardiovascular Disease, 12:38*

Treatment and Management of Upper Respiratory Tract Infections, 7:33*

Diagnostic Spotlight

Aptima HBV Quant Assay, 8:34

Guardian Connect Continuous Glucose-Monitoring System, 9:27

iPro2 Continuous Glucose Monitoring System, 5:31

Medtronic Deep Brain Stimulation System for Epilepsy, 11:30

RealTime CMV Assay, 12:36


Defending Flu Vaccines, 4:4

Diabetes Mainstay Might Defeat Colitis, 10:4

Food for Thought, 1:2

Genomics Targets Aggressive Breast Cancer, 9:2

Hair-Raising Research, 8:4

Heart Attack Harbinger?, 2:2

In-Pharmacy Asthma Testing Next?, 7:1

Making Its Mark on Crohn’s Disease, 12:4

Many-Pronged Approach, A, 3:4

Melanoma Menace, The, 6:3

Reducing Dementia Risk, 11:1

Specialty Pharmacy Serving Pediatric Patients, 5:3


Applying Recent A1C Recommendations in Clinical Practice, 10:15

Community and Specialty Pharmacy at a Crossroads, 4:33

Considerations in the Approach to Appropriate Statin Selection, 7:22

Crohn’s Disease Treatment Update, 12:16

Cystic Fibrosis: Update on Treatment Guidelines and New Recommendations, 5:16

Don’t Sweat It: An Overview of Hyperhidrosis, 6:15

Expanding Access to Naloxone, 3:16

Heart Failure Guidelines: Introduction to the New Agents, 2:22

Hormonal Contraceptive Consent by Minors: Implications for Pharmacists, 5:22

Hormone Replacement Therapy for Menopausal Symptoms, 9:21

Management of Helicobacter pylori Infection, 4:27

Management of Nightmare Disorder in Adults, 11:21

Managing Neurologic Complications of Chronic HCV Infection, 1:18

Medication Adherence: The Elephant in the Room, 1:30

Naltrexone for the Treatment of Alcohol Use Disorder in the Primary Care Setting, 8:26

Navigating the Generic Regulatory Landscape, 5:26

New Drug Review 2018, 10:42

Oral PDE5 Inhibitors for Erectile Dysfunction, 6:29

Overcoming Clinical Inertia in Diabetes Management: Pharmacist Opportunities, 10:25

Pharmacist’s Review of Asthma, A, 7:15

Pharmacist’s Role in Managing Microbial Keratitis, The, 7:27

Preventing and Treating Community-Acquired Pneumonia: A Focus on Men, 8:21

Recognizing and Effectively Treating Gastroparesis, 12:26

Reducing CV Events With Antihyperglycemic Drugs in Patients With Diabetes Mellitus, 2:32

Review of Diabetic Ketoacidosis Management, 11:26

Rheumatoid Vasculitis: A Complication of Rheumatoid Arthritis, 6:26

Role of Supplements in Diabetes Management, The, 10:35

Role of the Community Pharmacist in Mental Health, The, 11:13

Special Considerations for Opioid Use in Elderly Patients With Chronic Pain, 3:26

Travel Medicine Primer for the Pharmacist, A, 4:19

Treatment Options for Androgenetic Alopecia, 8:12

Patient Teaching Aids

Belly Fat in Men, 8:19

Colon Cancer, 12:13

Emphysema, 7:13

Juvenile Idiopathic Arthritis, 5:13

Low-Dose Aspirin, 2:11

Multiple Sclerosis, 1:11

Panic Attacks, 11:11

Psoriasis, 6:13

Shingles, 3:13

Tuberculosis, 4:13

Type 1 Diabetes, 10:23

Vaginal Dryness, 9:15

Pharmacy Focus

Assessing Novel Oral Anticoagulants, 2:13

Biofeedback Therapy: An Overview, 8:HS-13

Menopause: Changes and Challenges, 1:13

Nonstimulant Therapy for ADHD, 4:8

Pharmacy Law

Analyzing the Right to Try Act, 7:31

HIPAA and Sharing Information Related to Mental Health, 11:33

Women’s Reproductive Health and the Right to Not Dispense, 9:34

Senior Care

Cardiovascular Considerations With Prescription Opioids for Chronic Pain, 2:6

Nonopioid Analgesia Following Soft-Tissue–Tumor Surgery, 6:6

Nuances of Diabetic Foot Osteomyelitis in Older Adults, 10:10

Risk of Osteomyelitis With Joint Replacement, 4:16

Small-Intestine Cancer, IBD, and the Role of Gut Dysbiosis, 12:8

Treatment Nuances for Kaposi Sarcoma in Older Adults, 8:8


Apps Breathe New Life Into COPD Patients, 1:25

Deploying Artificial Intelligence Against Infectious Diseases, 3:21


Health-Related Office Visits by Children and Adolescents, 5:12

Influenza and Pneumonia Vaccination in Diabetic Patients, 4:45

Lifetime Asthma Prevalence and Attacks, 7:12

Manifestations of Chronic Pain, 3:41

Obesity and Physical Activity in Men, 8:18

Prevalence and Awareness of Prediabetes, 10:48

Prevalence of Infertility and Its Treatment Among Women, 9:14

Principal Diagnosis of GI Bleeding in Hospitalized Patients, 12:12

Trends in Controlled and Uncontrolled Hypertension, 2:10

Trends in Melanoma Prevalence, 6:12

Utilization of Mental-Health Services, 11:46


Generic Drug Review, June

Generic Drugs in the Pipeline: 2018 Update

Generic Medications: A Primer for Pharmacists and Patients

Parsing the Generic-Drug Approval Process

Specialty Pharmacy, Oncology & Hematology

Bladder Cancer Treatment Update, February

CAR-T Cells: Driving a New Era of Oncology Immunotherapy, November

Chemotherapy-Induced Nausea and Vomiting, February

Direct Oral Anticoagulants in Cancer Patients, August

Why We Need Standardized Performance Measures in Specialty Practice, November

Management of Bleeding in Patients Treated With Direct Oral Anticoagulants, November

Multiple Myeloma: Updates in Management, May

Review of Factor V Leiden Thrombophilia, A, May

Sickle Cell Disease Pain Management, August



Abnormal Uterine Bleeding: A Review, 9:HS-2

Addressing Hypoglycemic Emergencies, 10:HS-2

Clozapine-Induced Myocarditis, 11:HS-2

Counseling Patients About MI Recovery and Recurrence Prevention, 2:HS-8

Differentiating Upper and Lower GI Bleeds, 12:HS-2

Fetal Surgery Considerations for Pharmacists, 5:HS-8

Hyperosmolar Therapy for the Treatment of Cerebral Edema, 1:HS-8

Leptospirosis: Potential Rise From Hurricanes and Floods, 4:HS-2

Monitoring for Psychosis in Hospitalized Patients, 11:HS-8

Pharmacotherapy for Primary Headache Disorders in the Emergency Department, 3:HS-2

Prostate Cancer Review, 8:HS-7

Review of Selected NMEs, 10:HS-7

Review of the Diagnosis and Management of Pulmonary Arterial Hypertension, 3:HS-10

Review of the Opportunities and Shortcomings of Antibiotic Stewardship, A, 4:HS-7

Role of PARP Inhibitors in BRCA-Related Malignancies, 9:HS-10

Surgical Procedures for Obstructive Sleep Apnea, 1:HS-2

Topical Treatment of Dermatophytes and Candida in the Hospital Setting, 6:HS-9

Treacher Collins Syndrome, 5:HS-2

Treating Comorbid Depression in CVD Patients, 2:HS-2

Treatment of Pulmonary Embolism, 7:HS-2

Updates in Pharmacotherapy for Melanoma, 6:HS-2

* Available as online CE. Visit https://journalce.powerpak.com.